Log In
Print
BCIQ
Print
Print this Print this
 

APN201

  Manage Alerts
Collapse Summary General Information
Company Apeiron Biologics AG
DescriptionTopical liposomal formulation of a recombinant human superoxide dismutase (rhSOD)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today